4//SEC Filing
Johnson Michael Perkins 4
Accession 0000874716-24-000037
CIK 0000874716other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 5:56 PM ET
Size
15.0 KB
Accession
0000874716-24-000037
Insider Transaction Report
Form 4
Johnson Michael Perkins
Executive Vice President
Transactions
- Award
Non-Qualified Stock Option (right-to-buy)
2024-02-14+3,132→ 3,132 totalExercise: $560.56Exp: 2034-02-13→ Common Stock (3,132 underlying) - Exercise/Conversion
Restricted Stock Unit
2024-02-14−176→ 528 total→ Common Stock (176 underlying) - Award
Restricted Stock Unit
2024-02-14+714→ 714 totalExercise: $0.00→ Common Stock (714 underlying) - Exercise/Conversion
Common Stock
2024-02-14+176→ 243.342 total - Tax Payment
Common Stock
2024-02-14$560.56/sh−60$33,634→ 183.342 total - Award
Incentive Stock Option (right-to-buy)
2024-02-14+178→ 178 totalExercise: $560.56Exp: 2034-02-13→ Common Stock (178 underlying)
Footnotes (5)
- [F1]Includes a total of 51.542 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2023, June 30, 2023, September 29, 2023 and December 29, 2023.
- [F2]Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2025.
- [F3]Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2028.
- [F4]Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vest in four annual installments beginning on February 14, 2025.
- [F5]Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024.
Documents
Issuer
IDEXX LABORATORIES INC /DE
CIK 0000874716
Entity typeother
Related Parties
1- filerCIK 0001917747
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 5:56 PM ET
- Size
- 15.0 KB